Automera
1 known investors
Automera develops a drug-discovery platform that uses computational chemistry, AI, and quantum molecular dynamics to design chimeric small molecules with dual-binding capabilities targeting autophagy-driven degradation. Its approach addresses disease targets in areas such as cancer, inflammation, and the central nervous system.
Investors Β· 1
Frequently asked questions
- What does Automera do?
- Automera develops a drug-discovery platform that uses computational chemistry, AI, and quantum molecular dynamics to design chimeric small molecules with dual-binding capabilities targeting autophagy-driven degradation. Its approach addresses disease targets in areas such as cancer, inflammation, and the central nervous system.
- Who are Automera's investors?
- Automera's investors include ClavystBio.